Lam YY - Search Results

1

Occlusion of a Multilobed Shallow Left Atrial Appendage Using a Special LAmbre Device After Failed Watchman Implantation.

So CY, Lam YY, Cheung GS, Kam KK, Chan AK, Lee AP, Yan BP. So CY, et al. Among authors: lam yy. J Invasive Cardiol. 2019 Feb;31(2):E41-E42. J Invasive Cardiol. 2019. PMID: 30700631 Free article.

2

Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.

Yu CM, Chan YS, Zhang Q, Yip GW, Chan CK, Kum LC, Wu L, Lee AP, Lam YY, Fung JW. Yu CM, et al. Among authors: lam yy. J Am Coll Cardiol. 2006 Dec 5;48(11):2251-7. doi: 10.1016/j.jacc.2006.07.054. J Am Coll Cardiol. 2006. PMID: 17161255 Free article.

3

Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure.

Kum LC, Yip GW, Lee PW, Lam YY, Wu EB, Chan AK, Fung JW, Chan JY, Zhang Q, Kong SL, Yu CM. Kum LC, et al. Among authors: lam yy. Int J Cardiol. 2008 Mar 28;125(1):16-21. doi: 10.1016/j.ijcard.2007.02.016. Epub 2007 Apr 16. Int J Cardiol. 2008. PMID: 17433840 Clinical Trial.

4

Clinical manifestation and current management of patent foramen ovale.

Cruz-González I, Solis J, Kiernan TJ, Yan BP, Lam YY, Palacios IF. Cruz-González I, et al. Among authors: lam yy. Expert Rev Cardiovasc Ther. 2009 Aug;7(8):1011-22. doi: 10.1586/erc.09.62. Expert Rev Cardiovasc Ther. 2009. PMID: 19673678 Review.

5

Left atrial appendage-occluding devices for stroke prevention in patients with nonvalvular atrial fibrillation.

Yan BP, Kiernan TJ, Gonzales-Cruz I, Lam YY. Yan BP, et al. Among authors: lam yy. Expert Rev Med Devices. 2009 Nov;6(6):611-20. doi: 10.1586/erd.09.45. Expert Rev Med Devices. 2009. PMID: 19911873 Review.

6

Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel.

Ma TK, Lam YY, Tan VP, Kiernan TJ, Yan BP. Ma TK, et al. Among authors: lam yy. Pharmacol Ther. 2010 Feb;125(2):249-59. doi: 10.1016/j.pharmthera.2009.10.008. Epub 2009 Nov 14. Pharmacol Ther. 2010. PMID: 19919843 Review.

7

Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.

Yu CM, Chan JY, Zhang Q, Yip GW, Lam YY, Chan A, Burkhoff D, Lee PW, Fung JW. Yu CM, et al. Among authors: lam yy. JACC Cardiovasc Imaging. 2009 Dec;2(12):1341-9. doi: 10.1016/j.jcmg.2009.07.011. JACC Cardiovasc Imaging. 2009. PMID: 20083066 Free article. Clinical Trial.

8

Left atrial appendage exclusion: state-of-the-art.

Cruz-Gonzalez I, Yan BP, Lam YY. Cruz-Gonzalez I, et al. Among authors: lam yy. Catheter Cardiovasc Interv. 2010 Apr 1;75(5):806-13. doi: 10.1002/ccd.22344. Catheter Cardiovasc Interv. 2010. PMID: 20088009 Review.

9

Role of warfarin pharmacogenetic testing in clinical practice.

Tan GM, Wu E, Lam YY, Yan BP. Tan GM, et al. Among authors: lam yy. Pharmacogenomics. 2010 Mar;11(3):439-48. doi: 10.2217/pgs.10.8. Pharmacogenomics. 2010. PMID: 20402581 Review.

10

Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status.

Ma TK, Kam KK, Yan BP, Lam YY. Ma TK, et al. Among authors: lam yy. Br J Pharmacol. 2010 Jul;160(6):1273-92. doi: 10.1111/j.1476-5381.2010.00750.x. Br J Pharmacol. 2010. PMID: 20590619 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

275 results

Search Page

Filters